Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00869063 · ClinicalTrials.gov registry record · Phase 3
Diclofenac Patch for the Treatment of Acute Pain Due to Mild to Moderate Wrist Sprain, Strain or Contusion
A Phase 3 study of Acute Pain, sponsored by Cerimon Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 214
- Enrollment target
- 1
- Study location
NCT00869063: Completed Phase 3 study of Acute Pain, sponsored by Cerimon Pharmaceuticals.
NCT00869063 is a Phase 3 study of Acute Pain that has completed, run by Cerimon Pharmaceuticals. The registered enrollment target is 214 participants, below the 264-participant average among 50 other Acute Pain trials with a reported enrollment target (19% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00869063, a Phase 3 study of Acute Pain, has completed, sponsored by Cerimon Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 214 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to assess the effectiveness of once daily application of a diclofenac sodium topical patch in reducing acute pain due to mild to moderate wrist sprain, strain or contusion when applied to the painful area.
Conditions Studied
Interventions
- DRUG Matching Placebo Patch
- DRUG Diclofenac Sodium Patch
Study Locations (1)
Texas
- PPD - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-09 |
| Phase | Phase 3 |
What the finished NCT00869063 record still lists
NCT00869063 is an interventional study that assigns participants to a tested intervention. The registered 214 participants enrollment target is mid-sized for trials with a published cap, below the 264-participant average among 50 other Acute Pain trials with a reported enrollment target (19% lower).
The record links to 1 condition, with Acute Pain appearing as the primary indexed condition, and to 2 interventions - of which Matching Placebo Patch is the first listed.
NCT00869063 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00869063 about?
NCT00869063 is a clinical study titled "Diclofenac Patch for the Treatment of Acute Pain Due to Mild to Moderate Wrist Sprain, Strain or Contusion". The purpose of the study is to assess the effectiveness of once daily application of a diclofenac sodium topical patch in reducing acute pain due to mild to moderate wrist sprain, strain or contusion when applied to the painful area.
What is the current status of trial NCT00869063?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 214 participants. The study started on 2009-02. Estimated completion is 2009-09.
What conditions does trial NCT00869063 study?
This clinical trial studies the following conditions: Acute Pain.
What interventions are being tested in trial NCT00869063?
The interventions under investigation include: Matching Placebo Patch (DRUG), Diclofenac Sodium Patch (DRUG).
Who is sponsoring clinical trial NCT00869063?
This trial is sponsored by Cerimon Pharmaceuticals, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00869063 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00869063's enrollment target sits among peer trials
214 16th of 50 higher than 35 of 50 other Acute Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of XP20B Following Bunionectomy Surgery
COMPLETED · Phase 3
-
Efficacy of Lidocaine Patch in Acute Musculoskeletal Pain in the Emergency Department
COMPLETED · Phase 3
-
Erector Spinae Block Versus Surgeon Infiltration in VATS Procedures
COMPLETED · Phase 3
-
A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy
COMPLETED · Phase 3
-
Clinical Trial Comparing Two Protocols Using Intravenous (IV) Hydromorphone
COMPLETED · Phase 3
-
Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- NCT04421248 · 214 participants · Phase 4
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
- NCT04667520 · 214 participants · NA
Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment
- NCT05418868 · 214 participants · Phase 1
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia